(Press-News.org) Redirection of lymphocytes, via T-cell bispecific antibodies (TCBs) and chimeric antigen receptors (CARs), is already approved to treat some hematologic malignancies. In solid tumors these immune-based strategies continue to fail.
Research led by Joaquín Arribas, co-Program Director of Preclinical and Translational Research at VHIO, has now shown how HER2 breast cancer cells adopt a strategy to resist clearance by redirected lymphocytes. Findings evidence that the disruption of interferon-gamma signaling confers resistance to these immunotherapies and promotes disease progression.
These results, reported today in Nature Communications*, could help to potentiate future immune-based strategies and more precisely identify those patients who would be most likely to benefit from them.
Immunotherapy continues to show exciting promise in more effectively combating several tumor types. Many current strategies focus on ensuring the efficient delivery of active cytotoxic cells directly to tumors. It is thought that once the lymphocytes engage to cancer cells they will unfailingly destroy them, provided that inhibitory mechanisms are in check.
Results from a study published in Nature Communications*, now reveal how cancer cells escape death by lymphocytes through the disruption of interferon-gamma signaling. Co-first authored by Enrique J. Arenas and Alex Martínez-Sabadell, Post-doctoral Fellow and Graduate Student, respectively, of Joaquín Arribas' Growth Factors Group at VHIO, their findings show promise in potentiating future immune-based therapies against solid tumors.
Global research efforts centering on T cell-engaging therapies T-cell bispecific antibodies (TCBs) and chimeric antigen receptors (CARs), are heightening expectations for the more effective treatment of cancer.
"While these immune-based approaches have already been approved for the treatment of some hematologic malignancies, they fail to show efficacy in clinical studies with solid tumors. This failure has previously been associated with the incapacity of T-cells to successfully target cancer cells directly. Up until now, little has been reported on the mechanisms adopted by tumors which enable them to resist T-cell attack. This has been the focus of our present research," said Joaquín Arribas, co-Program Director of Preclinical and Translational Research at VHIO, ICREA Professor, CIBERONC Investigator, Director of the Hospital del Mar Medical Research Institute (IMIM), and Corresponding Author of this study.
He continued, "Several different strategies are now being implemented by the cancer research community to overcome these mechanisms of resistance. We aimed to go one step further by establishing whether more mechanisms exist that enable cancer cells to overcome the onslaught of targeted lymphocytes."
Using HER2-driven cell lines and PDXs, and a TCB and CAR targeting HER2, the investigators have now unmasked a novel mechanism of resistance to redirected T-cells. Specifically, they have discovered that even when active cytotoxic cells are successfully delivered to tumor cells, the latter adopt a strategy to avoid their elimination by lymphocytes. Findings suggest that the disruption of interferon-gamma signaling confers resistance and therefore promotes disease progression.
Interferon?gamma (IFN?γ) is a cytokine that assumes an important role in inducing and modulating an array of immune responses. "It acts as an interrupter that controls cell death. Certain cancer cells learn to switch off this pathway and thus survive the attack of lymphocytes. At present, there is no easy way of applying this discovery in clinical practice. Namely, to effectively identify those patients who have this pathway turned off. This represents a next step in our research; to develop a simple method to be able to do so," noted co-First Author, Enrique J. Arenas.
Previous research led by Joaquín Arribas published in Science Translational Medicine (2018) **, showed that the p95HER2-T-cell bispecific antibody can successfully guide lymphocytes directly to cancer cells for their targeted killing. This direct delivery was achieved thanks to the p95HER2 protein, which is only located in tumor cells. Representing a new therapeutic avenue and fresh hope for patients who have ceased to respond to current therapies, this novel immune-based approach can be used to tackle certain HER2+ breast cancers through its exclusive targeting of cancerous cells.
Building on these findings, the investigators hope to launch a new clinical trial in 2024-25 to further advance CAR-T targeting in breast cancer. "Driven by our discoveries, we aim to more precisely screen patients for enrollment in this clinical study, better predict when resistance will occur, and develop strategies to overcome the mechanisms that govern this resistance," concluded Joaquín Arribas.
This present research published today in Nature Communications also counted on the expertise and collaboration of investigators belonging to the VHIO-BBVA Foundation's Comprehensive Program of Cancer Immunotherapy & Immunology (CAIMI), and was supported through funding received from the Spanish Association against Cancer (Asociación Española contra el Cáncer - AECC), Breast Cancer Research Foundation (BCRF), and the Carlos III Health Institute (Instituto de Salud Carlos III - ISCIII).
INFORMATION:
References:
*Arenas EJ, Martínez-Sabadell A, Rius Ruiz I, Román Alonso M, Escorihuela M, Luque A, Fajardo CA, Gros A, Klein C and Arribas J. Acquired cancer cell resistance to T-cell bispecific antibodies and CAR- T targeting HER2 through JAK2 down-modulation. Nat. Commun. (2021). DOI: 10.1038/s41467-021-21445-4.
**Rius Ruiz I, Vicario R, Morancho B, Morales CB, Arenas EJ, Herter S, Freimoser-Grundschober A, Somandin J, Sam J, Ast O, Barriocanal ÁM, Luque A, Escorihuela M, Varela I, Cuartas I, Nuciforo P, Fasani R, Peg V, Rubio I, Cortés J, Serra V, Escriva-de-Romani S, Sperinde J, Chenna A, Huang W, Winslow J, Albanell J, Seoane J, Scaltriti M, Baselga J, Tabernero J, Umana P, Bacac M, Saura C, Klein C, Arribas J. p95HER2-T cell bispecific antibody for breast cancer treatment. Sci Transl Med. 2018 Oct 3;10(461):eaat1445.
About the Vall d'Hebron Institute of Oncology (VHIO):
Established in 2006, the Vall d'Hebron Institute of Oncology (VHIO) is a leading comprehensive cancer center of excellence where its scientists and research physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer.
Undertaking one of Spain's most dynamic cancer research programs, VHIO is dedicated to delivering on the promise of precision medicine in oncology - turning cancer discovery into more effective treatments and better practice for the care of our patients.
http://www.vhio.net
In a new study led by Yale Cancer Center, researchers demonstrate sex hormones and insulin growth factors are associated with recurrence risk of endometrial cancer. The findings suggest endocrine-targeted therapies and an assessment of biomarkers in hormone and insulin signaling pathways may be useful in the prevention and treatment of endometrial cancer recurrence. The study is a collaboration with researchers at the University of Hawaii and The International Agency for Research on Cancer (IARC) and is published online today in the journal Cancer Epidemiology Biomarkers and Prevention.
"These findings are very ...
WASHINGTON, February 23, 2021 -- One of the most performed medical diagnostic tests to ascertain the health of patients is a complete blood count, which typically includes an estimate of the hemoglobin concentration. The hemoglobin level in the blood is an important biochemical parameter that can indicate a host of medical conditions including anemia, polycythemia, and pulmonary fibrosis.
In AIP Advances, by AIP Publishing, researchers from SigTuple Technologies and the Indian Institute of Science describe a new AI-powered imaging-based tool to estimate hemoglobin levels. The setup was developed in conjunction with a microfluidic chip and ...
What The Study Did: A randomized clinical trial, this study reports that a layperson-delivered, empathy-oriented telephone call program reduced loneliness, depression and anxiety compared with the control group and improved the general mental health of participants within four weeks.
Authors: Maninder K. Kahlon, Ph.D., of the University of Texas at Austin, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(10.1001/jamapsychiatry.2021.0113)
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and ...
What The Article Says: In this narrative medicine essay, a medical school professor expresses gratitude for the caring and empathy expressed by the team caring for her mother hospitalized with COVID-19 and emphasizes the importance of humanity and compassion over facts and statistics for families physically separated from their critically ill loved ones.
Authors: Lisa M. Meeks, Ph.D., of the University of Michigan Medical School in Ann Arbor, is the author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2021.0119)
Editor's ...
What The Study Did: Researchers investigated whether children and adolescents who smoked or lived with a smoker had an increased risk of elevated blood pressure.
Authors: Rebecca V. Levy, B.M., B.Ch., M.Sc., of the Montefiore Medical Center in Bronx, New York is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2020.37936)
Editor's Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and ...
WASHINGTON, February 23, 2021 -- COVID-19 can spread from asymptomatic but infected people through small aerosol droplets in their exhaled breath. Most studies of the flow of exhaled air have focused on coughing or sneezing, which can send aerosols flying long distances.
However, speaking while near one another is also risky since the virus can be ejected by merely talking.
In Physics of Fluids, by AIP Publishing, scientists in Japan use smoke and laser light to study the flow of expelled breath near and around two people conversing in various relative postures commonly found in the service industry, such as in hair salons, medical exam rooms, or long-term care facilities. ...
WASHINGTON, February 23, 2021 -- As one of the leading sources of clean and renewable energy, global wind power capacity has increased more than fivefold over the past decade, leading to larger turbines and pushing wind technology to its limits.
"These much larger turbines are operating in very different atmospheric layers than smaller turbines used 5-10 years ago," said Srinidhi Gadde, one of the authors of a paper in the Journal of Renewable and Sustainable Energy, from AIP Publishing, that examines the impacts of turbine height. "At these scales, local meteorology and extreme shear events, which frequently occur, can impact ...
The plant that encourages kissing at Christmas is in fact a parasite, and new research reveals mistletoe has an unusual feeding strategy.
Like other plants, mistletoe is capable of using sunlight to create its own food, a process called photosynthesis. However, it prefers to siphon water and nutrients from other trees and shrubs, using "false roots" to invade its hosts.
"Plants are autotrophic, they make their own food. Humans are heterotrophic, we eat it," explained UC Riverside plant-insect ecologist Paul Nabity. "Mistletoe are mostly heterotrophic, but they can switch if they want to."
Nabity's team found when two mistletoes invade the same tree, they increase photosynthesis to get the nutrients they need, essentially sharing the ...
Kittens could be the model for understanding infectious, sometimes deadly, diarrheal disease in both animals and children, according to new research from North Carolina State University.
Diarrheagenic Escherichia coli (DEC) bacteria cause lethal diarrheal disease in children worldwide, killing up to 120,000 children under the age of five annually. Atypical enteropathic Escherichia coli (aEPEC) are a form of DEC increasingly associated with diarrheal disease in humans and in kittens.
"We were looking for causes of infectious diarrhea in kittens, which has a high mortality rate, and came across this pathogen," says Jody Gookin, FluoroScience Distinguished Professor in Veterinary Scholars Research Education at NC State and corresponding ...
Building upon previous research, an international team led by scientists at University of California San Diego School of Medicine, has validated a more inclusive and comprehensive genetic tool for predicting age of onset of aggressive prostate cancer, a disease that killed more than 33,000 American men in 2020.
Reporting in the February 23, 2021 online edition of Nature Communications, the researchers describe the performance of a polygenic hazard score (PHS) -- a mathematical estimate of an individuals' age-specific genetic risk for developing a disease -- in a multi-ethnic patient population.
"Genetic tools to predict a man's lifetime risk of prostate cancer might allow us to target cancer screening efforts to the men who are most likely to need it. We are ...
